Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Crossover Study of Valbenazine in Tardive Dyskinesia
NCT01393600Phase 2Completed
- Sponsor
- Neurocrine Biosciences
- Start
- Aug 2011
- Primary completion
- Feb 2012
- Modality
- Orthosteric Ligands, Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of valbenazine in tardive dyskinesia (TD), sponsored by Neurocrine Biosciences. Started Aug 2011; status: completed.
02
Drugs
valbenazine
03
Conditions
tardive dyskinesia (TD)
Beyond the preview
Go deeper on NCT01393600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01393600.